自体微碎片脂肪组织治疗骨关节炎:随机对照试验研究方案
本研究为盲法随机对照试验,将120例Kellgren-Lawrence 2-3级胫股关节骨关节炎患者按1:1分配至自体微碎片脂肪组织关节腔内注射组或等渗盐水对照组,主要结局为6个月时KOOS4评分,并随访至24个月。
要点
- 自体微碎片脂肪组织关节腔内注射可能缓解骨关节炎症状,但此前缺乏随机对照试验证据。
- 本研究以6个月KOOS4为主要结局,同时评估3、12、24个月KOOS、Tegner活动评分、治疗失败和工作状态。
- 纳入标准为因胫股关节骨关节炎(Kellgren-Lawrence 2-3级)导致疼痛和功能受损的患者。
核心结论
- 该试验旨在评估自体微碎片脂肪组织关节腔内注射治疗骨关节炎的疗效,目前尚无结论。
研究设计与样本
- 盲法随机对照试验,患者按1:1比例分配至2个平行组。
- 计划纳入120例Kellgren-Lawrence 2-3级胫股关节骨关节炎患者。
- 干预组接受自体微碎片脂肪组织(Lipogems®系统制备)关节腔内注射,对照组接受等渗盐水注射。
关键数值与推荐
- 主要结局为6个月时KOOS4评分。
- 次要结局包括3、12、24个月KOOS、Tegner活动评分、治疗失败和工作状态。
- 分析采用意向性治疗和符合方案分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteoarthritis is a destructive joint disease that leads to degeneration of cartilage and other morphological changes in the joint. No medical treatment currently exists that can reverse these morphological changes. Intra-articular injection with autologous, micro-fragmented adipose tissue has been suggested to relieve symptoms. METHODS/DESIGN: The study is a blinded randomized controlled trial with patients allocated in a 1:1 ratio to 2 parallel groups. Patients suffering from pain and functional impairment due to osteoarthritis Kellgren-Lawrence grades 2-3 in the tibiofemoral joint are eligible for inclusion. The intervention group is treated with an intra-articular injection with autologous, micro-fragmented adipose tissue prepared using the Lipogems® system. The control group receives an intra-articular injection with isotonic saline. In total, 120 patients are to be included. The primary outcome is The Knee injury and Osteoarthritis Outcome Score (KOOS4) evaluated at 6 months. Secondary outcomes are KOOS at 3, 12 and 24 months; the Tegner activity score; treatment failure; and work status of the patient. The analysis will be conducted both as intention-to-treat and per-protocol analysis. DISCUSSION: This trial is the first to investigate the efficacy of autologous, micro-fragmented adipose tissue in a randomized controlled trial. The study uses the patient-reported outcome measure Knee Injury and Osteoarthritis Outcome Score (KOOS4) after 6 months as the primary outcome, as it is believed to be a valid measure to assess the patient's opinion about their knee and associated problems when suffering from osteoarthritis.
引用
- Mikkelsen RK, Blønd L, Hölmich LR, et al. Treatment of osteoarthritis with autologous, micro-fragmented adipose tissue: a study protocol for a randomized controlled trial. Trials. 2021. PMID: 34706757. doi:10.1186/s13063-021-05628-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。